CelWel — Frequently Asked Questions

Product Basics

CelWel is a liquid sublingual supplement designed to support immune modulation and inflammatory balance.

CelWel is designed for individuals experiencing chronic inflammatory symptoms such as fatigue, brain fog, joint/muscle discomfort, immune dysfunction, Lyme-related symptoms, post-infection recovery, or chronic conditions that involve daily impairment from a “stuck” immune system.

No. CelWel is a non-prescription supplement.

No. CelWel has been studied in Lyme and post-infection recovery contexts, but the broader mechanism centers on immune modulation and inflammatory cytokine regulation.

How It Works

Most anti-inflammatories focus on reducing inflammation after it appears. CelWel is designed to support immune regulation — helping the body address the signaling process that may be driving unnecessary inflammation.

CelWel is better described as an immune modulator, supporting an appropriate immune response rather than broad stimulation.

Cytokines are signaling molecules used by the immune system. When inflammatory cytokines remain elevated, they can contribute to fatigue, pain, brain fog, and other chronic symptoms.

Usage & Dosing

CelWel is taken as sublingual drops in the mouth. Follow the product directions or your practitioner's guidance.

CelWel is positioned as a 3-week course.

Clinical materials reference a 3–7 day median time to improvement, with full benefit by day 21. Some patients notice improvement within 24–72 hours. Individual results vary.

⬡ Practitioner dosing protocol +

Practitioner-only · pending approval

Standard dosage noted in the practitioner materials is 0.4 mL — approximately 1 drop in the mouth, not more than one drop per 15 minutes. The protocol includes a loading phase on Day 1, adjustment on Days 2–3, and maintenance from Day 4 onward. Practitioners are encouraged to titrate based on individual patient response.

Safety

Published materials report no serious adverse events in studies, normal lab parameters, and no liver or kidney toxicity observed. Some Lyme patients reported mild to moderate Herxing.

CelWel may be used as a standalone approach or layered alongside existing treatments, protocols, or practitioner care. Please consult your healthcare provider when using CelWel with medications or active treatment plans.

Practitioner materials suggest no medication interactions were identified; this claim is pending review and approval before publishing. In the meantime, please consult your practitioner before combining CelWel with any medication or active treatment plan.

Results

In a 73-patient Lyme study, 75% of participants experienced meaningful improvement over 21 days. Reported improvements included cognitive function, energy/sleep, joint/muscle symptoms, digestive health, and overall symptom burden.

No. Individual results vary. The study data is encouraging, but no supplement can guarantee results for every person.

The comparison materials note a 25% non-responder rate in the 73-patient study, meaning CelWel may not be the right fit for everyone.

Practitioners

Yes. CelWel is designed to support practitioner-guided protocols, particularly for patients with chronic inflammatory symptoms, Lyme-related symptoms, post-treatment plateau, chemical sensitivities, and complex chronic illness patterns.

Practitioner materials identify potential candidates including chronic Lyme patients with inflammatory symptoms, patients at clinical plateau, those with chemical sensitivities, post-Lyme treatment persistent symptoms, and patients needing adjunctive immune support.

Orders & Shipping

Orders ship in discreet, protective packaging. Estimated delivery and tracking details are confirmed at checkout.

Yes — a reorder option is available on the Shop page, with the ability to repeat your course every 4 or 8 weeks and pause anytime.

Considered answers for a measured protocol.